title: Lamotrigine in Rett syndrome.
abstract: An elevated CSF glutamate level has recently been reported in Rett syndrome. Because the anticonvulsant effect of Lamotrigine is probably due to inhibition of glutamate release, this drug was given as an add-on drug to 4 girls with Rett syndrome. All patients responded with a seizure reduction of 50% or more and an improved well-being. A controlled study at the early stages of the syndrome could be interesting.
authors.affiliation: Child Department, Dianalund Epilepsy Hospital, Denmark.
authors.forename: P
authors.initials: P
authors.lastname: Uldall
authors.forename: F J
authors.initials: FJ
authors.lastname: Hansen
authors.forename: B
authors.initials: B
authors.lastname: Tonnby
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D002555:Cerebrospinal Fluid / Q000737:chemistry; D002648:Child; D002675:Child, Preschool; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D005971:Glutamates / Q000134:cerebrospinal fluid; D006801:Humans; D000077213:Lamotrigine; D015518:Rett Syndrome / Q000134:cerebrospinal fluid / Q000150:complications*; D016896:Treatment Outcome; D014227:Triazines / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000927:Anticonvulsants; D005971:Glutamates; D014227:Triazines; D000077213:Lamotrigine